Agilent Technologies, Inc. (NYSE:A) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Agilent Technologies logoShares of Agilent Technologies, Inc. (NYSE:A – Get Rating) have received an average recommendation of “Moderate Buy” from the fifteen brokerages that are presently covering the company, reports Marketbeat Ratings. Four analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $151.31.

A has been the subject of several analyst reports. Wells Fargo & Company upped their target price on Agilent Technologies from $130.00 to $135.00 and gave the company an “equal weight” rating in a report on Wednesday, August 17th. Credit Suisse Group assumed coverage on Agilent Technologies in a research note on Wednesday, August 24th. They issued an “outperform” rating and a $165.00 target price on the stock. StockNews.com assumed coverage on Agilent Technologies in a research note on Wednesday, October 12th. They issued a “strong-buy” rating on the stock. Cowen upped their price target on Agilent Technologies to $160.00 in a research note on Monday, August 22nd. Finally, Citigroup upped their price target on Agilent Technologies from $140.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, August 17th.

Agilent Technologies Trading Up 1.2 %

Shares of A stock opened at $146.19 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.94 and a quick ratio of 1.41. Agilent Technologies has a 1-year low of $112.52 and a 1-year high of $165.68. The company has a market cap of $43.28 billion, a price-to-earnings ratio of 33.30, a PEG ratio of 2.68 and a beta of 1.06. The stock has a 50-day simple moving average of $132.97 and a 200-day simple moving average of $127.82.

Want More Great Investment Ideas?

Agilent Technologies (NYSE:A – Get Rating) last issued its quarterly earnings results on Tuesday, August 16th. The medical research company reported $1.34 EPS for the quarter, topping the consensus estimate of $1.20 by $0.14. The firm had revenue of $1.72 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Agilent Technologies has a return on equity of 28.46% and a net margin of 19.94%. The firm’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same period in the previous year, the business earned $1.10 earnings per share. On average, equity research analysts expect that Agilent Technologies will post 5.07 EPS for the current fiscal year.

Agilent Technologies Increases Dividends

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 25th. Investors of record on Tuesday, January 3rd will be paid a dividend of $0.225 per share. This represents a $0.90 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date is Friday, December 30th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. Agilent Technologies’ dividend payout ratio (DPR) is currently 19.13%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, VP Padraig Mcdonnell sold 2,103 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total value of $258,437.67. Following the transaction, the vice president now directly owns 13,217 shares in the company, valued at approximately $1,624,237.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, VP Padraig Mcdonnell sold 2,103 shares of the firm’s stock in a transaction that occurred on Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total value of $258,437.67. Following the completion of the sale, the vice president now directly owns 13,217 shares of the company’s stock, valued at approximately $1,624,237.13. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed via this link. Also, SVP Michael Tang sold 3,600 shares of the firm’s stock in a transaction that occurred on Tuesday, November 1st. The shares were sold at an average price of $139.50, for a total value of $502,200.00. Following the completion of the sale, the senior vice president now directly owns 43,280 shares of the company’s stock, valued at $6,037,560. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 35,309 shares of company stock worth $4,846,147.

Hedge Funds Weigh In On Agilent Technologies

Several hedge funds and other institutional investors have recently bought and sold shares of A. Bromfield Sneider Wealth Advisors acquired a new position in Agilent Technologies during the second quarter worth $31,000. EverSource Wealth Advisors LLC increased its position in Agilent Technologies by 34.8% during the third quarter. EverSource Wealth Advisors LLC now owns 298 shares of the medical research company’s stock worth $37,000 after buying an additional 77 shares in the last quarter. Edge Capital Group LLC increased its position in Agilent Technologies by 53.0% during the third quarter. Edge Capital Group LLC now owns 303 shares of the medical research company’s stock worth $37,000 after buying an additional 105 shares in the last quarter. Guardian Wealth Advisors LLC purchased a new position in Agilent Technologies during the third quarter worth $42,000. Finally, JW Cole Advisors Inc. increased its position in Agilent Technologies by 7,201.6% during the first quarter. JW Cole Advisors Inc. now owns 124,493 shares of the medical research company’s stock worth $45,000 after buying an additional 122,788 shares in the last quarter.

About Agilent Technologies

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometers; real-time cell analyzers; cell imaging systems; microplate readers; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Read More

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Agilent Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.